SPONSOR
Charite University, Berlin, Germany
Total Trials
12
Recruiting
12
Phases
Phase 3
Conditions studied: B-Cell Acute Lymphoblastic LeukaemiaPsychotic DisordersSchizophrenia Spectrum Disorders (SSD)Atopic DermatitisMelanoma (Skin Cancer)Quality IndicatorsPost-intensive Care SyndromeProstate Cancer PatientsAdjacent Segment DiseaseLumbar Spinal Stenosis
Charite University, Berlin, Germany is a clinical research sponsor with 12 registered studies on ClinicalTrials.gov, of which 12 are actively recruiting participants. Research covers conditions including B-Cell Acute Lymphoblastic Leukaemia, Psychotic Disorders, Schizophrenia Spectrum Disorders (SSD), Atopic Dermatitis.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Charite University, Berlin, Germany
How many clinical trials has Charite University, Berlin, Germany sponsored?
ClinicalMetric currently tracks 12 clinical trials sponsored by Charite University, Berlin, Germany, of which 12 are actively recruiting participants. These trials cover conditions including B-Cell Acute Lymphoblastic Leukaemia, Psychotic Disorders, Schizophrenia Spectrum Disorders (SSD). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Charite University, Berlin, Germany research focus on?
Charite University, Berlin, Germany clinical trials span B-Cell Acute Lymphoblastic Leukaemia, Psychotic Disorders, Schizophrenia Spectrum Disorders (SSD), Atopic Dermatitis, Melanoma (Skin Cancer), and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Charite University, Berlin, Germany clinical trial?
To participate in a Charite University, Berlin, Germany trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Charite University, Berlin, Germany trials with current recruitment status updated daily.
Clinical Trials by Charite University, Berlin, Germany
NCT07476729 Phase 3
Recruiting
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
B-Cell Acute Lymphoblastic Leukaemia
NCT04730518
Recruiting
Yoga-based Group Intervention (YoGI) for In-patients With Schizophrenia Spectrum Disorders
Psychotic Disorders
NCT07265180
Recruiting
Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison
Schizophrenia Spectrum Disorders (SSD)
NCT05099315
Recruiting
Microbiome in Atopic Dermatitis Under Systemic Therapy
Atopic Dermatitis
NCT07680452
Recruiting
Clinical Study on High-fiber Diet and Short-term Fasting in Melanoma Under Immunotherapy With Checkpoint Inhibition
Melanoma (Skin Cancer)
NCT07501494
Recruiting
Evaluation of Quality Indicators in Patients Receiving Intensive Care and Their Influence on Outcome Indicators and Economic Indicators
Quality Indicators
NCT07371741
Recruiting
PICS Clinic Attendance and Recovery Engagement (PICS-CARE)
Post-intensive Care Syndrome
NCT07156903
Recruiting
Evaluation of Needs of Patients and Care-givers During and After Radiotherapy of Patients With Prostate Cancer
Prostate Cancer Patients
NCT07661199
Recruiting
Surgical Treatment of Adjacent Segment Stenosis
Adjacent Segment Disease
NCT04754854
Recruiting
Reduction of Blood Recirculation in Veno-Venous ECMO
Extracorporeal Membrane Oxygenation
NCT04793828
Recruiting
A Transdiagnostic, Self-guided Internet Intervention ("Velibra") for Waitlist Patients With Anxiety Disorders
Panic Disorder With Agoraphobia
NCT04355195
Recruiting
Quality Contract: Prevention of Postoperative Delirium in the Care of Older Patients (QV-POD-2)
Delirium in Old Age
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology